Martin Devenport (Past Speaker)

Martin has a background in molecular biology and approximately 10 years of corporate experience in the biotech industry. Prior to joining OncoImmune, he was Vice President of Business Strategy at Amplimmune, Inc. where his responsibilities included overseeing all project management and operation activities. Consequently he is experienced with all aspects of the drug development process, including research, development, GMP manufacturing, regulatory and clinical trials. Martin has a proven track record developing pre-clinical assets through IND submission and into early clinical stage development. In addition, Martin has helped secure millions of dollars in government grants and formed licensing partnerships with industry partners for each stage assets. Martin was an integral member of the business development team that lead to its successful sale to MedImmune for up to $500 million in 2013.